title: Essential hypertension: polymorphonuclear leukocyte membrane fluidity at baseline and after chemotactic activation.
authors.forename: G
authors.initials: G
authors.lastname: Caimi
authors.forename: R
authors.initials: R
authors.lastname: Lo Presti
authors.forename: B
authors.initials: B
authors.lastname: Canino
authors.forename: M
authors.initials: M
authors.lastname: Montana
authors.forename: G
authors.initials: G
authors.lastname: Cerasola
mesh_terms: D000328:Adult; D000368:Aged; D001794:Blood Pressure; D002630:Chemotactic Factors / Q000494:pharmacology*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000097:blood*; D008297:Male; D008560:Membrane Fluidity / Q000187:drug effects; D008875:Middle Aged; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000494:pharmacology; D018375:Neutrophil Activation / Q000187:drug effects; D009504:Neutrophils / Q000187:drug effects / Q000378:metabolism*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
chemical_list: D002630:Chemotactic Factors; D009240:N-Formylmethionine Leucyl-Phenylalanine; D013755:Tetradecanoylphorbol Acetate